Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
US Department of Justice
Boehringer Ingelheim
Teva
Chinese Patent Office
Julphar
Healthtrust
AstraZeneca
Moodys
Cipla

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200656

« Back to Dashboard

NDA 200656 describes PERIKABIVEN IN PLASTIC CONTAINER, which is a drug marketed by Fresenius Kabi Usa and is included in one NDA. It is available from one supplier. Additional details are available on the PERIKABIVEN IN PLASTIC CONTAINER profile page.

The generic ingredient in PERIKABIVEN IN PLASTIC CONTAINER is amino acids; calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium acetate; sodium glycerophosphate; soybean oil. There are three hundred and forty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium acetate; sodium glycerophosphate; soybean oil profile page.
Suppliers and Packaging for NDA: 200656
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
KABIVEN IN PLASTIC CONTAINER amino acids; calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium acetate; sodium glycerophosphate; soybean oil EMULSION;IV (INFUSION) 200656 NDA Fresenius Kabi USA, LLC 63323-712 63323-712-25 2566 mL in 1 BAG (63323-712-25)
KABIVEN IN PLASTIC CONTAINER amino acids; calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium acetate; sodium glycerophosphate; soybean oil EMULSION;IV (INFUSION) 200656 NDA Fresenius Kabi USA, LLC 63323-712 63323-712-20 2053 mL in 1 BAG (63323-712-20)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:EMULSION;IV (INFUSION)Strength2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML)
Approval Date:Aug 25, 2014TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:EMULSION;IV (INFUSION)Strength2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML)
Approval Date:Aug 25, 2014TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:EMULSION;IV (INFUSION)Strength2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML)
Approval Date:Aug 25, 2014TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
UBS
Argus Health
Chinese Patent Office
US Department of Justice
Daiichi Sankyo
Teva
Mallinckrodt
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot